MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-08-2026
Pacific Biosciences of California Total Inventories 2011-2026 | PACB
Annual Total Inventories Pacific Biosciences of California
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.3 M | 58.8 M | 56.7 M | 50.4 M | 24.6 M | 14.2 M | 13.3 M | 17.9 M | 23.1 M | 15.6 M | 11 M | 11.3 M | 10 M | 9.59 M | 15.5 M | 6.86 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 58.8 M | 6.86 M | 24.3 M |
Quarterly Total Inventories Pacific Biosciences of California
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 M | 53.2 M | 53.8 M | 54 M | 58.8 M | - | - | 67.3 M | 56.7 M | 68.3 M | 67.6 M | 62 M | 50.4 M | 43.5 M | 36.1 M | 29.6 M | 24.6 M | 18.3 M | 18 M | 16.3 M | 14.2 M | 14.2 M | 14.2 M | 14.2 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 11 M | 11 M | 11 M | 11 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 10 M | 10 M | 10 M | 10 M | 9.59 M | 9.59 M | 9.59 M | 9.59 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 68.3 M | 9.59 M | 24.1 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
Co-Diagnostics
CODX
|
992 K | $ 5.63 | -2.26 % | $ 7.49 M | USA |
 |
Castle Biosciences
CSTL
|
10.3 M | $ 21.01 | -2.73 % | $ 609 M | USA |
 |
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
2.85 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
85.9 M | $ 125.61 | -5.6 % | $ 15.7 B | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
1.11 M | $ 1.67 | -6.7 % | $ 7.39 M | USA |
 |
Illumina
ILMN
|
564 M | $ 162.32 | -3.42 % | $ 25.2 B | USA |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 22.25 | -3.76 % | $ 1.19 B | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 149.45 | -2.19 % | $ 11.7 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
64.7 M | $ 100.98 | -1.79 % | $ 6.82 B | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M |  China |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
28.6 M | $ 10.9 | -3.63 % | $ 1.4 B | USA |
 |
Natera
NTRA
|
68.4 M | $ 215.31 | -3.06 % | $ 29.4 B | USA |
 |
Charles River Laboratories International
CRL
|
299 M | $ 181.34 | -2.4 % | $ 8.99 B | USA |
 |
Mettler-Toledo International
MTD
|
387 M | $ 1 154.33 | -2.22 % | $ 23.8 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
30.6 M | $ 4.57 | -2.56 % | $ 423 M | USA |
 |
Senseonics Holdings
SENS
|
6.7 M | $ 6.67 | -4.85 % | $ 278 M | USA |
 |
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
15 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.49 M | $ 2.12 | -1.17 % | $ 4.87 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 265.15 | 1.6 % | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
28.3 M | $ 69.22 | -6.37 % | $ 4.14 B | USA |
 |
Thermo Fisher Scientific
TMO
|
5.42 B | $ 472.8 | -1.91 % | $ 178 B | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K |  Israel |
 |
Waters Corporation
WAT
|
572 M | $ 365.36 | -2.95 % | $ 21.8 B | USA |
 |
Neogen Corporation
NEOG
|
191 M | $ 8.9 | -2.41 % | $ 1.93 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 200.29 | 2.13 % | $ 22.2 B | USA |